RD-1A Survey of Industrial Research & Development

M

R

S

BU

EA

US

CE
ER

U.S.
D

A

M

EP

Attachment 3
MENT OF CO
RT

EN
U O
F TH E C

U.S. DEPARTMENT OF COMMERCE
Economics and Statistics Administration

U.S. CENSUS BUREAU
FORM

RD-1A

2007 SURVEY OF INDUSTRIAL RESEARCH AND
DEVELOPMENT
OMB No. 0607-0912: Approval Expires 12/31/2007

(DRAFT)

Mail your completed form to:
U.S. CENSUS BUREAU
1201 East 10th Street
Jeffersonville, IN 47132-0001
Please read the accompanying
instructions before answering the
questions.
Need help or have questions
about filling out this form?
Visit our Web site at
www.census.gov/econhelp/rd
To speak with an analyst, call 1800-851-2014, option "0" between
8:00 a.m. and 5:00 p.m., Eastern
time, Monday through Friday.
- OR Write to the address above,
include your 11-digit Identification
Number (ID) printed in the mailing
address.
Option to file electronically is
located at
www.census.gov/econhelp/rd

(Please correct any errors in this mailing address.)
YOUR RESPONSE IS REQUIRED BY LAW. Title 13, United States Code, requires businesses and other organizations
that receive this questionnaire to answer the questions and return the report to the U.S. Census Bureau. By the same
law, YOUR CENSUS REPORT IS CONFIDENTIAL. It may be seen only by persons sworn to uphold the confidentiality
of Census Bureau information and may be used only for statistical purposes. Further, copies retained in respondents'
files are immune from legal process. Data supplied in all items for 2007 on this form will satisfy the mandatory reporting
requirements. (Title 13, U.S. Code.) Except as noted in specific questions, this report should cover your entire consolidated
domestic enterprise, including all subsidiaries in the 50 United States and D.C. Reasonable estimates are acceptable.
This survey is conducted jointly with the National Science Foundation.
RESEARCH AND DEVELOPMENT (R&D)
R&D includes basic and applied research in the
sciences and engineering. It also includes design
and development of new products and processes and
enhancement of existing products and processes.
R&D includes activities carried on by persons
trained, either formally or by experience, in the
physical sciences such as chemistry and physics,
the biological sciences such as medicine, and
engineering and computer science. R&D includes
these activities if the purpose is to do one or more of
the following things:
1. Pursue a planned search for new scientific
knowledge or understanding that does not have
specific immediate commercial objectives, although
it may be in fields of present or potential commercial
interest. (Basic research)

11001013

2. Apply the findings of basic research or other
existing knowledge toward discovering new
scientific knowledge that has specific commercial
objectives, including work required to evaluate
possible uses, with respect to new products, services,
processes, or methods. (Applied research)

3. Systematically use the knowledge or
understanding gained from research and practical
experience in the production or significant
improvement of products, services, processes, or
methods, including the design and development
of prototypes, materials, devices, and systems.
(Development)
Research and development includes the activities
described above whether assigned to separate R&D
organizational units of the company or carried out
by company laboratories and technical groups not
part of an R&D organization. Reporting the R&D
activities of such latter groups may require the use of
estimates for some of your responses.
Activities to be excluded from R&D are as follows:
research in social sciences or psychology, routine
product testing, geological and geophysical
exploration activities and technical services.

See instructions for more detail.
1

Did your company conduct R&D in 2007? (Mark "X" only ONE box.)
201

Yes - Complete form, enter zeros where applicable, and return this form.

203

No - Either call TDE to report (1-800-851-2014) OR mark the 203 box and mail the form.
NOTE - After reviewing

USCENSUSBUREAU

1

if you need further assistance please call 1-800-851-2014, option "0".
CONTINUE ON PAGE 2

Form RD-1A

Page 2

(DRAFT)

2007

Dollar figures should be rounded to thousands of dollars.

$ Billions

Millions

If a figure is $1,025,628.79: Report
2

3

4

What was the amount of your company's sales,
shipments, operating receipts, or revenues, net
of returns and allowances attributable to domestic
operations in the 50 United States or D.C. during
2007? (EXCLUDE domestic intracompany transfers
and sales by foreign subsidiaries. INCLUDE receipts
for sales of products and services provided to other
companies, individuals, U.S. Government agencies,
and foreign countries.) . . . . . . . . . . . . . . . Mark "X" if None
How many employees worked in the 50 United
States or D.C. for your company on March 12, 2007?
(INCLUDE number of full- and part-time employees
whose payroll was reported on Internal Revenue
Service Form 941, Employer's Quarterly Federal Tax
Return.) . . . . . . . . . . . . . . . . . . . . . . Mark "X" if None

Thousands

1 0 2 6

2007
$ Billions

Millions

Thousands

102

0130

Number
112

0131

What was the number of full-time equivalent (FTE) scientists and engineers
employed by your company as of January 1, 2008 who worked on R&D in the
50 United States and D.C. during 2007?

January 1, 2008
Number of FTEs
206

(See Instructions for the definition of FTE scientists
and engineers.) . . . . . . . . . . . . . . . . . . Mark "X" if None
5

0134

What was the cost of R&D performed within your company in the 50 United
States and D.C. from each of the sources of funding below during 2007?
2007

A. Basic research (Activity
toward the advancement
of scientific knowledge
without specific immediate
commercial objectives.)
Mark "X" if no
basic research

$ Billions

(1)

(2)

(3)

Federal funds

Company and other
nonfederal funds

Total funds
Columns 1 + 2

Millions

Thousands

$ Billions

Millions

Thousands

$ Billions

304

305

306

314

315

316

324

325

326

344

345

346

Millions

Thousands

0135

B. Applied research
(Activity directed primarily
towards a specific
commercial or practical
objective.)
Mark "X" if
no applied
research. . . .

0136

C. Development (Activity
translating research into
new or improved products,
services, or processes.)

11001021

Mark "X" if no
development

0137

D. TOTAL (Add lines A
through C.)
Mark "X" if no
R&D . . . . . 0138
6

2008

If your company plans to
perform R&D during 2008,
what is the projected cost?
(Comparable to the 2007
figure reported in 5 , line D.)
Mark "X" if no
R&D is planned
for next year . . .

$ Billions
403

(1)

(2)

(3)

Federal funds

Company and other
nonfederal funds

Total funds
Columns 1 + 2

Millions

Thousands

$ Billions
402

Millions

Thousands

$ Billions

Millions

Thousands

401

0139

CONTINUE ON PAGE 3

Form RD-1A

Page 3

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.
7

If others outside your company performed R&D funded by your company, what was the cost of the R&D performed
in the 50 United States and D.C. during 2007?
2007
(Include payments made via
(2)
(3)
contracts, grants, or other
(1)
agreements under which
Total
funds
Company and other
Federal funds
your company pays for but
nonfederal funds
Columns 1 + 2
does not perform any of
$ Billions
Millions
Thousands $ Billions
Millions
Thousands $ Billions
Millions
Thousands
the R&D.)
Mark "X" if
no R&D was
performed by
others . . . . . .

8 and 9

354

355

356

0140

Not Applicable.

10 If your company funded R&D performed outside
the 50 United States and D.C. during 2007, what
was the cost? (Please report costs of R&D performed
by subsidiaries, affiliates, or others based on your
company's percentage of ownership, if any, of the
entity that conducted the R&D. Ownership can be
based on voting stock or equivalent interest.)
Mark "X" if None 0147
A. More than 50% ownership (This category includes wholly
owned subsidiaries and locations.) . . . . . . . . . . . .

2007
Company and other
nonfederal funds
$ Billions

Millions

Thousands

366

365

B. 10% to 50% ownership . . . . . . . . . . . . . . . . .
364

C. More than 0% but less than 10% ownership . . . . . . .
363

D. 0% - No company ownership . . . . . . . . . . . . . .
369

E. TOTAL (Add lines A through D.) . . . . . . . . . . . . .

11001039

11 and 12 Not Applicable.

CONTINUE ON PAGE 4

Form RD-1A

Page 4

(DRAFT)

13 For the total R&D you reported in 5 , line D, column 3, what
was the cost for each of the following types of expenses?

2007
Total funds
$ Billions

A. Wages and salaries of R&D personnel
(INCLUDE scientists and
engineers, technicians,
secretaries, and other
personnel.) . . . . . . . . . Mark "X" if None

B. Fringe benefits of R&D personnel
(INCLUDE taxable and
nontaxable benefits,
401K plans, employers'
contribution to health plans.) Mark "X" if None

C. Materials and supplies consumed
(INCLUDE the cost of
all purchased materials
consumed.) . . . . . . . . Mark "X" if None

D. Depreciation on R&D property
and equipment
(INCLUDE depreciation
and amortization costs for
property and equipment
used for R&D during the
year.) . . . . . . . . . . . Mark "X" if None

E. All other R&D expenses
(INCLUDE R&Ds share
of company overhead
and other expenses such
as utilities, books and
periodicals, and property and
other taxes.) . . . . . . . . Mark "X" if None

Thousands

611

0166

621

0167

631

0168

641

0169

651

0170

661

0171

11001047

F. TOTAL(Add lines A through
E. The sum should equal the
total reported in 5 , line D,
column 3.) . . . . . . . . . Mark "X" if None

Millions

CONTINUE ON PAGE 5

Form RD-1A

Page 5

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.
14 For the total R&D you reported in 5 , line D, column 3, what
were the costs for the following areas?

2007
Total funds
$ Billions

A. Biotechnology (The use of
scientific and engineering
data and techniques for
the study and solution of
problems concerning living
organisms.) . . . . . . . . Mark "X" if None
B. Software development (The
formulation of programs,
applications, routines, etc.,
for computers, excluding
those used exclusively
for internal company
operations.) . . . . . . . . Mark "X" if None
C. Materials synthesis and
processing (The use of
scientific and engineering
data and techniques
for the formulation and
manipulation of new
materials.) . . . . . . . . . Mark "X" if None

Millions

Thousands

7111

0172

7211

0173

7311

0174
7411

D. All other areas . . . . . . . Mark "X" if None
E. TOTAL(Add lines A through
D. The sum should equal the
total reported in 5 , line D,
column 3.) . . . . . . . . . Mark "X" if None
15

0175

7511

0176

Did your company perform any R&D using nanotechnology during 2007? (Nanotechnology is the creation and
utilization of materials, devices, and systems sized at the level of atoms and molecules. This includes R&D in the range
of 1 to 100 nanometers.)

7001

Yes - Go to 16 .

7002

No - Go to 19 .

16 For the R&D costs reported in 14 , lines A through D, what
percentage involved the use of nanotechnology for each of
the following areas?

2007
Whole
percents
7112

A. Biotechnology . . . . . . . Mark "X" if None

%

0177

11001054

7212

B. Software development . . . Mark "X" if None

%

0178
7312

C. Materials synthesis and
processing . . . . . . . . . Mark "X" if None

%

0179
7412

D. All other areas . . . . . . . Mark "X" if None

0180

%

17 and 18 Not Applicable.

CONTINUE ON PAGE 6

Form RD-1A

Page 6

(DRAFT)

19 A. Does this report cover your entire consolidated domestic enterprise, including all U.S.
subsidiaries? (Mark "X" only ONE box.)
1301

Yes

1330

No - Please explain in 21 .

B. Was this company owned or controlled by another company on December 31, 2007?
001

Yes - Give date acquired at right AND enter new owner
name and mailing address below
6030

Name of new owner or operator

6031

Mailing address (Number and street, P.O. box, etc.)

6032

City, town, village, etc.

Month

6033

Year

State

6034

ZIP Code

No
CHECK ITEM - Please complete the check list below BEFORE returning this form. By checking these items you will reduce the
likelihood of our calling you to resolve an error or inconsistency.
In

2

: Are sales reported in thousands of dollars?
Yes
No

In

3

: Does your answer describe the number of employees, NOT company payroll?
Yes
No

In 5 : Does the Federal funds (column 1) plus Company funds (column 2) equal Total funds (column 3)
for each of the following rows?
Basic research ( 5 A), applied research ( 5 B), development ( 5 C), total research and development ( 5 D).
Yes
No

11001062

If the answer to any of the above checks is "No," please make the necessary corrections in the appropriate item(s) or provide
an explanation in 21 .

CONTINUE ON PAGE 7

Form RD-1A

Page 7

(DRAFT)

If not shown, please enter your 11-digit Identification
Number (ID) from the mailing address.
20 Reporting period, location of records, and contact information
A. Is the time period covered by this report a calendar year?
Month

0078

Yes

0079

No - Enter time period covered

Year

Month

0070

Year

0071

FROM

TO

B. Are all of your company's R&D records and data in a central location?
0080

Yes

0081

No - How many locations?

0085

Other - Please describe

0086

0087

C. How many people were involved in the preparation of this report (INCLUDE those you
consulted who provided, collected, or reviewed information, even if you are the only one
who filled out the form.)? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
0072

Name of person to contact regarding this report

Area code

Telephone

0074

Number

-

0073

0084

Title

Extension

Area code

Fax

Number

-

0075

Month
0076

Internet e-mail address

Date
completed

Day

0069

11001070

21 REMARKS (Please use this space for any explanations that may help us in understanding your reported data.)

Thank you for completing your 2007 SURVEY OF INDUSTRIAL RESEARCH AND
DEVELOPMENT form.
PLEASE PHOTOCOPY THIS FORM FOR YOUR RECORDS AND RETURN THE ORIGINAL.

Year